Current topics

  • Antidote for paracetemol overdoses: Drug could save hundreds of people
    Article on Aladote:  A REVOLUTIONARY drug could save hundreds of people from paracetamol poisoning.

  • Peripheral Neuropathy Awareness Week
    This week is the Peripheral Neuropathy Awareness Week. Peripheral neuropathy is a set of symptoms caused by damage to the nerves in the arms and legs. These distant nerves are called peripheral nerves. They carry sensations to the brain and control our arms and legs. Some of the chemotherapy, for example oxaliplatin, and other drugs ...

  • Article on Aladote in FirstWorldPharma
    Read the full article here: FirstWorldPharma

  • PledPharma initiates clinical study on new treatment for paracetamol poisoning
    PledPharma initiates clinical study on new treatment for paracetamol poisoning PledPharma has recieved approval from the MHRA, the UK’s medicines regulatory body, to undertake a clinical trial for Aladote®, a new treatment for reducing liver damage from paracetamol (acetaminophen) poisoning. Paracetamol poisoning affects approximately 50,000 people the UK every year. The trial will evaluate the safety ...

  • Nicklas Westerholm – new CEO
    We welcome Nicklas Westerholm as the new CEO of PledPharma. Nicklas will take office on June 16. Nicklas Westerholm, is a business leader with extensive management experience (20 years) across multiple geographies within the pharmaceutical industry. Management experience gained from a broad range of senior executive management roles globally within Research & Development, Manufacturing & Supply ...

See more articles


Year end report 2016

Carnegie Healthcare Seminar

Annual General Meeting

Interim Report Jan – March 2017

Interim Report Jan – June 2017

Interim Report Jan – Sept 2017

Press releases